Immunomedics Inc. (IMMU)

15.44
NASDAQ : Health Technology
Prev Close 15.86
Day Low/High 14.86 / 15.86
52 Wk Low/High 11.55 / 24.99
Avg Volume 2.23M
Exchange NASDAQ
Shares Outstanding 191.98M
Market Cap 3.04B
EPS -1.70
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Shareholder Alert: Robbins Arroyo LLP Reminds Investors Immunomedics, Inc. (IMMU) Sued For Misleading Shareholders

Shareholder Alert: Robbins Arroyo LLP Reminds Investors Immunomedics, Inc. (IMMU) Sued For Misleading Shareholders

Shareholder rights law firm Robbins Arroyo LLP reminds investors that purchasers of Immunomedics, Inc.

M&A Appetite in Pharma Has Proved Potent: Chart of the Day

M&A Appetite in Pharma Has Proved Potent: Chart of the Day

With total deals trending toward hundreds of billions, investors may be eager to bet on who's next to be acquired.

First Week Of IMMU February 2020 Options Trading

First Week Of IMMU February 2020 Options Trading

Investors in Immunomedics, Inc. saw new options become available this week, for the February 2020 expiration.

2 Biotech Names See Directors Direct Cash to Their Shares

2 Biotech Names See Directors Direct Cash to Their Shares

The stock purchases by the insiders are at companies developing treatments for breast cancer and schizophrenia.

IMMUNOMEDICS 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Deadline In Class Action Lawsuit Against Immunomedics, Inc. - IMMU

IMMUNOMEDICS 24 HOUR DEADLINE ALERT: Approximately 24 Hours Remain; ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Deadline In Class Action Lawsuit Against Immunomedics, Inc. - IMMU

ClaimsFiler, a FREE shareholder information service, reminds investors that they have only until February 25, 2019 to file lead plaintiff applications in a securities class action lawsuit against Immunomedics, Inc.

INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline In Securities Fraud Class Action Lawsuit Filed Against Immunomedics, Inc.

INVESTOR REMINDER: Kessler Topaz Meltzer & Check, LLP Announces Deadline In Securities Fraud Class Action Lawsuit Filed Against Immunomedics, Inc.

The law firm of Kessler Topaz Meltzer & Check, LLP alerts Immunomedics, Inc. (NASDAQ: IMMU) ("Immunomedics") investors that two securities fraud class action lawsuits have been filed in the United States District Court for the District of New Jersey (the...

Robbins Geller Rudman & Dowd LLP Announces A Securities Case Has Been Filed On Behalf Of Purchasers Of Immunomedics, Inc. Securities

Robbins Geller Rudman & Dowd LLP Announces A Securities Case Has Been Filed On Behalf Of Purchasers Of Immunomedics, Inc. Securities

Robbins Geller Rudman & Dowd LLP announces that a securities class action case has been filed on behalf of purchasers of Immunomedics, Inc.

IMMUNOMEDICS SHAREHOLDER ALERT: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Immunomedics, Inc. - IMMU

IMMUNOMEDICS SHAREHOLDER ALERT: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Immunomedics, Inc. - IMMU

ClaimsFiler, a FREE shareholder information service, reminds investors that they have until February 25, 2019 to file lead plaintiff applications in a securities class action lawsuit against Immunomedics, Inc.

Cohen Milstein Sellers & Toll PLLC Announces Investigation Of Immunomedics, Inc.

Cohen Milstein Sellers & Toll PLLC Announces Investigation Of Immunomedics, Inc.

Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether Immunomedics, Inc.

Deadline Reminder: The Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Immunomedics, Inc.

Deadline Reminder: The Law Offices Of Howard G. Smith Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Immunomedics, Inc.

Law Offices of Howard G. Smith reminds investors of the February 25, 2019 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased Immunomedics, Inc.

IMMU LOSS NOTICE: Rosen Law Firm Reminds Immunomedics, Inc. Investors Of Deadline In Case Seeking To Recover Investor Losses - IMMU

IMMU LOSS NOTICE: Rosen Law Firm Reminds Immunomedics, Inc. Investors Of Deadline In Case Seeking To Recover Investor Losses - IMMU

Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Immunomedics, Inc.

Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Immunomedics, Inc.

Kessler Topaz Meltzer & Check, LLP Announces Investor Securities Fraud Class Action Lawsuit Filed Against Immunomedics, Inc.

The law firm of Kessler Topaz Meltzer & Check, LLP reminds that an investor securities fraud class action lawsuit has been filed against Immunomedics, Inc.

Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Immunomedics, Inc. Investors

Law Offices Of Howard G. Smith Announces The Filing Of A Securities Class Action On Behalf Of Immunomedics, Inc. Investors

Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors that purchased Immunomedics, Inc.

Scott Scott Attorneys At Law LLP Alerts Investors To Securities Class Action Against Immunomedics, Inc.

Scott Scott Attorneys At Law LLP Alerts Investors To Securities Class Action Against Immunomedics, Inc.

Scott+Scott Attorneys at Law LLP ("Scott+Scott"), a national shareholder and consumer rights litigation firm, is notifying investors that a class action lawsuit has been filed against Immunomedics, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Immunomedics, Inc.

EQUITY ALERT: Rosen Law Firm Announces Filing Of Securities Class Action Lawsuit Against Immunomedics, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of the securities of Immunomedics, Inc.

Noteworthy Tuesday Option Activity: IMMU, KODK, APTI

Noteworthy Tuesday Option Activity: IMMU, KODK, APTI

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Immunomedics, Inc. , where a total volume of 13,064 contracts has been traded thus far today, a contract volume which is representative of approximately 1.3 million underlying shares (given that every 1 contract represents 100 underlying shares).

Interesting IMMU Put And Call Options For December 21st

Interesting IMMU Put And Call Options For December 21st

Investors in Immunomedics, Inc. saw new options begin trading this week, for the December 21st expiration.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BLFS, BOSC, HESM, PLAB, PSEC Downgrades: CREE, IMMU Initiations: FPH, RNGR Read on to get TheStreet Quant Ratings' detailed report:

3 Biotech Stock Favorites to Bet on Today: Top Analysts

3 Biotech Stock Favorites to Bet on Today: Top Analysts

Follow the experts. These biotech stocks have Wall Street's best analysts getting bullish.

The Charts of Immunomedics Look Very Bullish Now

The Charts of Immunomedics Look Very Bullish Now

Let's look at the charts and indicators to come up with a formula for success.

Tuesday Investor Blog: Is the Bull Market in Stocks Being Ripped to Shreds?

Tuesday Investor Blog: Is the Bull Market in Stocks Being Ripped to Shreds?

Bring your A-game in these markets or go home. Just keeping it real. Here is what you need to know on Tuesday.

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

15 Biotech Firms That Have Strong Potential to Be Acquired: Jefferies

'Balance sheets are flush with cash and there is a need to grow for large health care companies,' Jefferies analysts wrote.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: EOCC, FET, IMMU, INVA, KMDA, SPH Downgrades: COR, EARN, EML, ENS, MSON, MYL, NCR, OFC, PBH, PCYO, THR, UBA, UBNT, UFS, WHG Initiations: None Read on to get TheStreet Quant Ratings' detailed report: